TrianglePUBLICATIONS · 21130701
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer Cell
- Publication date
- 2010 Dec 14
- First author
- Figueroa ME
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Figueroa ME
- type
- Author
- name
- Abdel-Wahab O
- type
- Author
- name
- Lu C
- type
- Author
- name
- Ward PS
- type
- Author
- name
- Patel J
- type
- Author
- name
- Shih A
- type
- Author
- name
- Li Y
- type
- Author
- name
- Bhagwat N
- type
- Author
- name
- Vasanthakumar A
- type
- Author
- name
- Fernandez HF
- type
- Author
- name
- Tallman MS
- type
- Author
- name
- Sun Z
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Figueroa ME
- type
- Author
- name
- Abdel-Wahab O
- type
- Author
- name
- Lu C
- type
- Author
- name
- Ward PS
- type
- Author
- name
- Patel J
- type
- Author
- name
- Shih A
- type
- Author
- name
- Li Y
- type
- Author
- name
- Bhagwat N
- type
- Author
- name
- Vasanthakumar A
- type
- Author
- name
- Fernandez HF
- type
- Author
- name
- Tallman MS
- type
- Author
- name
- Sun Z
- type
- Author
- bibliography ids
- nci-bib-0bf1b33026f3ac25b95b3d4b
- book metadata
- content sha256
- ed6df79538e6f3da64634d568cb9f8763d35b0b732b17f85d80a9cd8b702bfd4
- document type
- citation
- dois
- 10.1016/j.ccr.2010.11.015
- electronic publication date
- display
- 2010 Dec 9
- precision
- day
- year
- 2010
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:21130701
- immutable id
- pubmed:21130701@ed6df79538e6f3da64634d568cb9f8763d35b0b732b17f85d80a9cd8b702bfd4
- journal
- abbreviation
- Cancer Cell
- issn electronic
- 1878-3686
- issn print
- 1535-6108
- issue
- 6
- name
- Cancer cell
- nlm unique id
- 101130617
- pages
- 553-67
- volume
- 18
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 21130701
- provenance
- batch id
- edef4b7f1a2a505cd5a9
- provider
- NCBI PubMed ESummary
- record sha256
- 0e5f2230cdebc511edecc6b82a50656fa7242497d4d37702aeda8a8eb2239b56
- response sha256
- d2d0fd7c34783716c953156f8a1da1b7b36c4823b416656eca04a1e69e03a295
- retrieved at
- 2026-09-09T23:46:38.027615+00:00
- publication date
- display
- 2010 Dec 14
- precision
- day
- year
- 2010
- publication types
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.
Preserved source evidence · Independent clinical review pending · Not medical advice